What does icon do in clinical research?
Clinical Research Services ICON provides a range of integrated services that cover the planning, management, execution and analysis of Phase II – IIIb trials. Consulting ICON Consulting Services provides strategic analysis to support improved decision-making in drug and device development.
How can icon help you?
Transforming recruitment through patient-centric trials and real-world, real-time data. ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation. From recruitment of a single clinical professional to managing entire global functions.
What services does icon offer?
Clinical, consulting and commercial services. ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.
How do I access Icon's network resources remotely?
There are several methods to access ICON's network resources remotely. Listed below are links to each of ICON's remote services, accompanied by a brief description to assist you in determining which of the remote access technologies best suit your needs. Remote Desktop connects directly to ICON's network as if you were in the office.
What does ICON plc stand for?
ICON Public Limited CompanyICON Public Limited Company is a clinical research organisation (CRO).
Is ICON a good company to work for?
Is ICON a good company to work for? ICON has an overall rating of 3.8 Average Rating out of 5, based on over 34 ICON Review Ratings left anonymously by ICON employees, which is 3% lower than the average rating for all companies on CareerBliss. 88% of employees would recommend working at ICON.
What does ICON do?
ICON is an American Irish-headquartered healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. As of November 2021, ICON had 38,000 employees in 147 locations spread across 46 countries.
Is ICON a CRO?
ICON Plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide.
Does ICON give bonuses to employees?
The salary is very competitive, though no bonus structure.
Is Icons legit?
Icons Shop Ltd is the world's leading football memorabilia company and Icons.com is the most trusted brand in the game.
Who is icon owned by?
Jonathan Ward, founder and CEO of Icon, is curious to a fault. The 49-year-old incessantly asks questions to better understand his grossly disparate fascinations, and his offbeat, witty personality influences the design and funk of every Icon built.
Whats it like to work at icon?
My experience has been great. They have a great training program, and the people on my team make for a healthy work culture (good WLB, responsive to our obstacles etc.). There's plenty of resources available to help us do our jobs effectively; as well as, plenty of opportunities to learn about the CRO as a whole too.
Is icon a good CRO?
ICON previously won the SCRIP Best CRO Award in 2019 and 2017. This latest recognition as the Best Contract Research Organisation continues ICON's winning streak of awards and accolades this year. It comes on the heels of ICON being named one of the World's Best Employers for 2021 by global media company Forbes.
Is ICON the biggest CRO?
According to an investor presentation, ICON ranks as the sixth largest CRO measured by revenue while PRA is the fifth largest. The combined company would rank as the second largest CRO, trailing the approximately $5.8 billion that IQVIA generates from contract services.
What is the largest CRO?
IQVIAAs the largest CRO in the world, IQVIA operates in over 100 countries across the globe and brings together advances in data science, technology, and human science expertise, offering their clients an end-to-end clinical and commercial service.
When did ICON acquire PRA?
February 2021ICON has concluded the previously announced acquisition of contract research company PRA Health Sciences for a total consideration of approximately $12bn. The companies signed a merger agreement in February 2021, under which ICON paid $80 in cash per share and 0.4125 shares of its stock to PRA shareholders.
Whats it like to work at ICON?
My experience has been great. They have a great training program, and the people on my team make for a healthy work culture (good WLB, responsive to our obstacles etc.). There's plenty of resources available to help us do our jobs effectively; as well as, plenty of opportunities to learn about the CRO as a whole too.
Is ICON a good CRO?
ICON previously won the SCRIP Best CRO Award in 2019 and 2017. This latest recognition as the Best Contract Research Organisation continues ICON's winning streak of awards and accolades this year. It comes on the heels of ICON being named one of the World's Best Employers for 2021 by global media company Forbes.
How many employees does ICON plc have?
39,300 employeesICON currently has over 39,300 employees in 115 locations in 46 countries. ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology, medical device and government and public health organisations to bring new treatments to market faster.
Who is the CEO of ICON plc?
Steve Cutler (Mar 1, 2017–)ICON plc / CEO
What is diversity initiative?
Diversity initiatives are a hallmark of clinical research. From US Food and Drug Administration (FDA)-penned guidance and pharma initiatives.
Is glycomics a study?
Glycomics has been a largely overlooked area of study. Nevertheless, it has the potential to have a significant impact on precision medicine and healthcare as a whole.
What is icon methodology?
ICON’s methodology for project delivery gives clients a novel, best-in-class approach to improve cycle times, constrain costs and reduce risks in clinical trials.
What is icon development?
ICON’s development experts apply their expertise to make products and treatments accessible to patients through our Site & Patient Solution — whether it’s patient insight for optimised trial design, engagement with patient advocacy groups or customized patient recruitment strategies.
How do we increase predictability in patient recruitment?
We increase predictability in patient recruitment by making it easier for the site and the patient.
Experience and expertise to guide you through the process
Decentralised and hybrid trials bring a wide range of benefits to the patient and the sponsor. However, every study needs to be assessed for suitability and requires a framework based on a range of different aspects and considerations.
Bringing benefits to your study
In addition to addressing the challenge of patient recruitment and retention, DCTs bring other benefits to your study including:
What are the concerns of ICON and Intel?
ICON and Intel explore industry concerns about implementation of this technology in a clinical trial, including patient acceptance, device suitability, data complexity and insight generation, operationalisation, privacy and security issues, and regulatory acceptance.
Is mHealth a digital trial?
Although mHealth devices and sensors are continuing to evolve, and it is now possible to capture a vast array of physiological data, the operationalization of digital trial is not without challenges.
